Welcome to the Cufence® Website
To continue please select your Country
Reporting suspected adverse reactions after authorisation of the medicinal product is important. Any suspected adverse reactions should be reported via the national reporting systems. Adverse events related to Cufence® can also be reported to Univar Solutions BV by telephone on +44 (0)1628 531171 or by emailing email@example.com.